BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry. METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.
BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry. METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.
Authors: Judith A Cook; Jane K Burke-Miller; Dennis D Grey; Jennifer Cocohoba; Chenlong Liu; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Pamela J Steigman; Mardge H Cohen Journal: AIDS Behav Date: 2014-06
Authors: Jon C Mills; Jeffrey S Harman; Robert L Cook; Nicole M Marlow; Christopher A Harle; R Paul Duncan; Angela M Bengtson; Brian W Pence Journal: J Affect Disord Date: 2017-03-19 Impact factor: 4.839
Authors: Maria Ferrara; Anya Umlauf; Chelsea Sanders; Jonathan M Meyer; John Allen McCutchan; Nichole Duarte; Joseph Hampton Atkinson; Igor Grant; Ronald J Ellis Journal: Psychiatry Res Date: 2014-04-18 Impact factor: 3.222